Rubric Capital Management LP
Source: SEC Form 13F · as of Mar 2026Rubric Capital Management LP holds 16 biotech & pharma companies tracked by BioSniper, totaling $1.51B in value as of Mar 2026 (SEC Form 13F).
Companies held
16
Total value held
$1.51B
BioSniper AIPage evidence connected
Prepared research question
What matters most for Teva Pharmaceutical Industries Limited (TEVA)—catalysts, financial risk and supporting evidence?
Run cited research
Traceable citations · Unknowns marked
| Company | Shares | Value |
|---|---|---|
| TEVATeva Pharmaceutical Industries Limited | 15,250,000 | $459.3M |
| ARQTArcutis Biotherapeutics, Inc. | 8,271,577 | $194.9M |
| KNSAKiniksa Pharmaceuticals International, plc | 3,750,000 | $180.6M |
| ZYMEZymeworks Inc. | 7,000,000 | $175.3M |
| ROIVRoivant Sciences Ltd. | 5,000,000 | $138.5M |
| SPRYARS Pharmaceuticals, Inc. | 8,000,000 | $64.2M |
| OPKOPKO HEALTH, INC. | 47,791,243 | $54.5M |
| PRTAPROTHENA CORP PUBLIC LTD CO | 5,000,000 | $48.6M |
| PTGXProtagonist Therapeutics, Inc | 427,998 | $45.1M |
| NRIXNurix Therapeutics, Inc. | 2,473,885 | $38.3M |
| ABUSArbutus Biopharma Corp | 6,626,389 | $29.8M |
| BMRNBIOMARIN PHARMACEUTICAL INC | 440,560 | $24.9M |
| HRTXHERON THERAPEUTICS, INC. /DE/ | 30,046,828 | $24.0M |
| ADMAADMA BIOLOGICS, INC. | 1,809,408 | $16.3M |
| ARDXARDELYX, INC. | 1,860,896 | $11.1M |
| EDSAEdesa Biotech, Inc. | 687,500 | $3.6M |
13F holdings reflect long positions in U.S.-listed securities as reported to the SEC. Values are point-in-time for the most recent reported quarter.